You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪瑞醫療(300396.SZ):12項醫療器械產品取得CE認證證書
格隆匯 12-25 20:45

格隆匯12月25日丨迪瑞醫療(300396.SZ)公佈,公司的12項醫療器械產品於近日取得了CE認證證書。

產品名稱分別為:胃蛋白酶原I測定試劑盒(化學發光免疫分析法)、胃蛋白酶原II測定試劑盒(化學發光免疫分析法)、皮質醇測定試劑盒(化學發光免疫分析法)、生長激素測定試劑盒(化學發光免疫分析法)、層粘連蛋白測定試劑盒(化學發光免疫分析法)、腎素測定試劑盒(化學發光免疫分析法)、透明質酸測定試劑盒(化學發光免疫分析法)、IV型膠原測定試劑盒(化學發光免疫分析法)、促腎上腺皮質激素測定試劑盒(化學發光免疫分析法)、骨鈣素測定試劑盒(化學發光免疫分析法)、降鈣素原測定試劑盒(化學發光免疫分析法)、尿分析複合質控液。

化學發光免疫分析作為體外診斷行業最重要的細分項目之一,其臨牀應用涵蓋多個病種,包括腫瘤、甲功、激素、傳染病、心臟標誌物等。化學發光免疫分析技術目前在歐美等發達國家已經成為臨牀試驗室廣泛使用的常規檢測技術。

尿液分析技術目前在國內外已經成為臨牀檢驗項目的常規檢測技術,隨着國內廠商技術不斷進步,與國外尿液分析產品的差距不斷縮小,公司在尿液分析領域多年來積累了較強的產品、品牌優勢和技術儲備。

上述產品取得CE認證證書,表明了該產品符合歐盟相關要求,已經具備歐盟市場的准入條件,將進一步增強公司產品的綜合競爭力,有利於進一步提高公司的市場拓展能力,對公司未來的經營將產生積極影響。上述產品實際銷售情況取決於未來市場推廣效果,公司目前尚無法預測其對公司未來業績的影響,敬請投資者注意投資風險。公司未來會積極推動相關產品在國際市場的銷售,為廣大股東創造更大的價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account